Trends in Long Term Outcomes Among Patients With Antineutrophil Cytoplasmic Antibody Associated Vasculitis With Renal Disease
It is still not clear how advances in the management of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) have impacted long term outcomes. We undertook this study to examine changes over 25 years in long term clinical outcomes, including the impact of renal function at diagnosis (a potential marker of time to disease detection) and the duration of cyclophosphamide use in AAV patients with renal involvement.
Arthritis rheumatology